5 Most Promising Stocks to Buy Before They Take Off

Page 1 of 5

In this article, we discuss the 5 most promising stocks to buy before they take off. To read the detailed analysis of the current earnings week, go directly to the 10 Most Promising Stocks to Buy Before They Take Off.

5. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Performance (YTD) as of April 23: -23.20%

Average Upside Potential as of April 23: 49.07%

Number of Hedge Fund Holders: 44

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a Massachusetts-based company that discovers, develops, and commercializes novel therapeutics. According to our database, 44 hedge funds held stakes in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) in the fourth quarter of 2023, with positions worth $582.613 million. With 1.111 million shares of the company worth $212.677 million, VenBio Select Advisor is the largest shareholder of the company, as of December 31, 2023. The stock has gone down by 23.20% year-to-date, as of April 23.

On April 7, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported positive results from the KARDIA-2 Phase 2 study for Zilebesiran for the treatment of hypertension. The study reached the primary endpoint and key secondary endpoint, and the investigational RNAi therapeutic has the potential of two doses per year.

In the last three months, 21 Wall Street analysts have covered Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), and 13 keep a Buy rating on the stock. The average price target of $223.00 represents an upside of 49.07% to the present levels, as of April 23. The stock ranks among our most promising stocks to buy before they take off.

Follow Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Page 1 of 5